Introduction
This document serves as a formal correction to a 2011 study published in Oncogene. The primary objective is to rectify an image duplication error in Figure 1a. Despite this clerical correction, the authors emphasize that the original quantitative data and the fundamental conclusions regarding the mechanisms of breast cancer progression remain unchanged.
The Challenge of Cancer Progression
A central question in oncology is how premalignant lesions—cells harboring initial mutations—transition into invasive, life-threatening tumors. This research specifically examines HER2-positive lesions. While HER2 overexpression is a known driver of breast cancer, it is often insufficient on its own to trigger invasive behavior. The study investigates how external growth factors (GFs), specifically Epidermal Growth Factor (EGF), act as environmental triggers that cooperate with genetic mutations to drive invasion.
Methodology
The study utilized the MCF10A human mammary epithelial cell line as a "normal" model, alongside a variant engineered to overexpress HER2 (MCF10A-HER2). To quantify invasiveness, a Transwell Invasion Assay was employed:
- Barrier Setup: Cells were seeded onto a Transwell filter coated with Matrigel, which simulates the extracellular matrix.
- Stimulation: Experimental groups were treated with EGF (20 ng/ml).
- Detection: After 12 hours, cells that successfully invaded through the Matrigel and migrated to the opposite side of the filter were stained with crystal violet.
- Quantification: The extent of invasion was measured via optical density (OD).
Key Insights: The Synergy of HER2 and EGF
The corrected Figure 1a illustrates a critical concept in cancer biology: synergy between internal genetic states and external signals.
- HER2 as a Primer: Overexpression of HER2 alone (bottom-left) induces some cellular changes but does not lead to widespread invasion in the absence of external growth factors.
- EGF as a Trigger: The addition of EGF to HER2-overexpressing cells (bottom-right) results in a dramatic, non-linear increase in invasive capacity.
- Multi-Hit Hypothesis: These findings support the "multi-hit" model of cancer progression, where a genetic mutation (HER2) primes the cell, and an environmental signal (EGF) propels it toward malignancy.
Quantitative Results
The quantitative data presented in the bar graph corroborates the visual evidence from the microscopic images.
- Control MCF10A: Showed negligible invasion regardless of EGF presence.
- MCF10A-HER2 (No EGF): Exhibited a baseline invasion level (OD ~0.2).
- MCF10A-HER2 (+ EGF): Demonstrated a massive surge in invasion (OD ~0.45), more than doubling the invasive capacity compared to the HER2-only group.
Conclusion
This correction reinforces the integrity of the original study's findings. The data suggests that blocking external growth factor signals could be a viable strategy for preventing HER2-positive premalignant lesions from progressing to invasive disease. While the in vitro Matrigel model has limitations in replicating the full complexity of the human breast environment, it provides a robust framework for understanding the molecular drivers of cancer progression.
Summary updated